Onco-Innovations Revises Pricing on $2 Million Private Placement

Onco-Innovations Ltd. ( (TSE:ONCO) ) just unveiled an update.

Onco-Innovations has amended the pricing of its previously announced non-brokered private placement and now plans to issue up to 3,076,923 units at $0.65 per unit, for gross proceeds of up to $2 million. Each unit will consist of one common share and one warrant exercisable at $0.75 for three years, with additional shares to be paid as an administrative fee and potential finder fees or warrants for intermediaries.

The financing remains subject to regulatory approvals and a standard four-month-plus-one-day hold period on all securities issued. Proceeds are earmarked for general corporate and working capital needs, including support for operational and R&D objectives and investor relations, underscoring the company’s effort to strengthen its balance sheet while advancing its oncology technology platform.

More about Onco-Innovations Ltd.

Onco-Innovations Limited is a Canadian oncology-focused company dedicated to cancer research and treatment. It pursues the prevention and treatment of cancer through pioneering research and innovative solutions and holds an exclusive worldwide licence to patented technology targeting solid tumours.

Average Trading Volume: 32,599

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$84.6M

See more data about ONCO stock on TipRanks’ Stock Analysis page.